// App-Quantinova.ai

e19090 : The role of circulating free DNA (cfDNA) and circulating tumor cells (CTC) in advanced non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy (CHT).

Researchers

Presenter

  • Carlo Genova

Principal Investigators

  • Anna Truini

  • Maria Giovanna Dal Bello

  • Simona Coco

  • Angela Alama

  • Irene Vanni

  • Francesco Grossi

  • Erika Rijavec

  • Giulia Barletta

  • Federica Biello

Medical Centers

  • Lung Cancer Unit, IRCCS AOU San Martino - IST - Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Solute Carrier Family 5 Member 7

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved